These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 20136960

  • 21. Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.
    Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Bertin E, Luise A, Frego M, Plebani M, Sturniolo GC, D'Amico DF, Angriman I.
    Dis Colon Rectum; 2007 Jun; 50(6):861-9. PubMed ID: 17473939
    [Abstract] [Full Text] [Related]

  • 22. Fecal excretion of alpha 2-macroglobulin: a novel marker for disease activity in patients with inflammatory bowel disease.
    Becker K, Niederau C, Frieling T.
    Z Gastroenterol; 1999 Jul; 37(7):597-605. PubMed ID: 10458008
    [Abstract] [Full Text] [Related]

  • 23. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 24. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 25. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
    Yüksel O, Helvaci K, Başar O, Köklü S, Caner S, Helvaci N, Abayli E, Altiparmak E.
    Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
    [Abstract] [Full Text] [Related]

  • 26. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.
    Clin Lab; 2005 Jun; 51(3-4):117-26. PubMed ID: 15819166
    [Abstract] [Full Text] [Related]

  • 27. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM, Beglinger C, Straumann A, Trummler M, Vavricka SR, Bruegger LE, Seibold F.
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [Abstract] [Full Text] [Related]

  • 28. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
    Zezos P, Papaioannou G, Nikolaidis N, Patsiaoura K, Vassiliadis T, Mpoumponaris A, Giouleme O, Evgenidis N.
    Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
    [Abstract] [Full Text] [Related]

  • 29. A systematic prospective comparison of noninvasive disease activity indices in ulcerative colitis.
    Turner D, Seow CH, Greenberg GR, Griffiths AM, Silverberg MS, Steinhart AH.
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1081-8. PubMed ID: 19577010
    [Abstract] [Full Text] [Related]

  • 30. Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
    Uehara T, Kato K, Ohkusa T, Sugitani M, Ishii Y, Nemoto N, Moriyama M.
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S62-6. PubMed ID: 20586868
    [Abstract] [Full Text] [Related]

  • 31. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
    Bolge SC, Waters H, Piech CT.
    Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
    [Abstract] [Full Text] [Related]

  • 32. Utility of a rapid fecal latex agglutination test detecting the neutrophil protein, lactoferrin, for diagnosing inflammatory causes of chronic diarrhea.
    Fine KD, Ogunji F, George J, Niehaus MD, Guerrant RL.
    Am J Gastroenterol; 1998 Aug; 93(8):1300-5. PubMed ID: 9707055
    [Abstract] [Full Text] [Related]

  • 33. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
    Valentini L, Schaper L, Buning C, Hengstermann S, Koernicke T, Tillinger W, Guglielmi FW, Norman K, Buhner S, Ockenga J, Pirlich M, Lochs H.
    Nutrition; 2008 Aug; 24(7-8):694-702. PubMed ID: 18499398
    [Abstract] [Full Text] [Related]

  • 34. A fulminant colitis index greater or equal to 8 is not predictive of colectomy risk in infliximab-treated moderate-to-severe ulcerative colitis attacks.
    Baudet A, Colombel JF, Cortot A, Dupas JL, Brazier F, Savoye G, Lerebours E, Justum AM, Reimund JM.
    Gastroenterol Clin Biol; 2010 Nov; 34(11):612-7. PubMed ID: 20832218
    [Abstract] [Full Text] [Related]

  • 35. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997 Nov; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 36. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
    Ng LL, Pathik B, Loke IW, Squire IB, Davies JE.
    Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837
    [Abstract] [Full Text] [Related]

  • 37. [Fecal excretion of short-chain fatty acids as a marker of the severity of ulcerative colitis].
    Kosacheva TA, Sil'vestrova SIu, Drozdov VN.
    Ter Arkh; 2010 Jul; 82(2):48-51. PubMed ID: 20387676
    [Abstract] [Full Text] [Related]

  • 38. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
    Hafer A, Krämer S, Duncker S, Krüger M, Manns MP, Bischoff SC.
    BMC Gastroenterol; 2007 Sep 04; 7():36. PubMed ID: 17784949
    [Abstract] [Full Text] [Related]

  • 39. Study on the correlations among disease activity index and salivary transforming growth factor-beta 1 and nitric oxide in ulcerative colitis patients.
    Rezaie A, Khalaj S, Shabihkhani M, Nikfar S, Zamani MJ, Mohammadirad A, Daryani NE, Abdollahi M.
    Ann N Y Acad Sci; 2007 Jan 04; 1095():305-14. PubMed ID: 17404043
    [Abstract] [Full Text] [Related]

  • 40. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ, Sfakianakis M, Archavlis E, Petraki K, Christidou A, Karagiannidis A, Triadaphyllou G.
    Am J Gastroenterol; 2004 Jun 04; 99(6):1122-8. PubMed ID: 15180735
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.